Supernus Pharmaceuticals | SUPN - Spese Operative





Spese Operative Cambiamento Data
Abbott USD 11.66B 1.2B 2026-09
ANI Pharmaceuticals USD 637.11M 39.9M 2026-09
Aurora Cannabis CAD 76.28M 28.24M 2026-06
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Canopy Growth CAD 98.74M 23K 2026-06
Cara Therapeutics USD 7.05M 1.11M 2026-03
Corcept Therapeutics USD 225.75M 10.9M 2026-09
Eisai JPY 218.93B 9.33B 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Novo Nordisk DKK 44.73B 7.52B 2026-06
Pacira USD 1.18B 995.96M 2026-09
Perrigo USD 961.4M 670.9M 2026-09
Pfizer USD 89B 3.81B 2026-09
Supernus Pharmaceuticals USD 1.06B 31.25M 2026-09
United Therapeutics USD 6.28B 124.3M 2026-09
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06